Open an account

Hypha Labs

FUNI · OTC

$0.0043+$0.0001 (+2.38%)TodayMarket closed ·
No price history for this range.

About FUNI

Hypha Labs, Inc. engages in the research, development, and commercialization of a bioreactor. The company is headquartered in Las Vegas, Nevada and currently employs 5 full-time employees. The company went IPO on 2011-12-23. The Hypha Micropearl bioreactor is a home appliance designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company’s device, together with its replacement cartridges, produces enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contain active mushroom ingredients that offer a way to harness the medicinal properties of fungi in a concentrated easy to handle tasteless and odorless form. These Micropearls can be incorporated into various food and beverages without altering the flavor. The QR codes on the cartridges are scanned to the Hypha Lab app and inserted into the device and the Micropearls are produced and fully formed in eight days. Its Hypha Micropearl bioreactor is to be sold with replaceable cartridges.

Employees
5
Headquarters
Las Vegas, Nevada
Listed
Dec 23, 2011
Sector
Consumer Discretionary
Industry
Household Durables
Website
hyphalabs.com

FUNI key statistics

Market cap
688.36K
Price-earnings ratio
—
Dividend yield
—
Average volume
51.00K
Volume
443
Open price
$0.0043
High today
$0.0043
Low today
$0.0043
52 Week high
$0.04
52 Week low
$0.0023

Hypha Labs (FUNI) at a glance

As of Oct 20, 2026, Hypha Labs (FUNI) shares are priced at $0.0043, giving the company a market cap of 688.36K.

Volume so far is 443 shares, below the average of 51.00K shares a day.

Over the past year Hypha Labs has ranged from $0.0023 to $0.04, and now sits 5% of the way up that range.

FUNI news

  • Press releaseACCESS Newswire

    Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics

  • Press releaseACCESS Newswire

    Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing

  • Press releaseACCESS Newswire

    Hypha Labs Expands List of Functional Mushrooms Able to be Produced in its Revolutionary Mushroom Accelerator

  • Press releaseACCESS Newswire

    Hypha Labs Provides Shareholder Update

  • Press releaseACCESS Newswire

    Hypha Labs Files New Patent Application for Its Suite of Artificial Intelligence (AI) Techniques for Its Mushroom Accelerator

  • Press releaseACCESS Newswire

    Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator

  • Press releaseGlobe Newswire

    Emerging Markets Report: A Milestone for Mycelium

  • Press releaseACCESS Newswire

    Hypha Labs Acquires State-of-the-Art HPLC Analytic Machine and Partners with Lucidity Systems for Advanced Autosampler Upgrade

Similar companies

Companies in the same industry as Hypha Labs

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.